ASCO GU 2008 - Cardiovascular Mortality Following Androgen Deprivation Therapy For Locally Advanced Prostate Cancer: Analysis Of ROG 85-31

Main Category: Prostate / Prostate Cancer
Also Included In: Cardiovascular / Cardiology;  Men's health;  Clinical Trials / Drug Trials
Article Date: 16 Feb 2008 - 1:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:5 stars

5 (1 votes)


UroToday.com - Androgen-deprivation therapy (ADT) decreases PCSM, but may be associated with greater risk of incident coronary artery disease (CAD), myocardial infarction and diabetes. Data from RTOG 85-31, a large trial of radiotherapy with or without ADT was used for this analysis. 945 men were randomized, and 50% of men were over age 70. Median duration of ADT was 4.2 years, and 64% of the radiotherapy patients ultimately received ADT at a mean time interval of 3 years.

A total of 574 deaths occurred, and 117 were CV related. No ADT related increase in CV mortality was found. In multivariate analysis of CV mortality with and without censoring at time of salvage ADT, ADT was not associated with increased CV mortality in men with locally advanced CaP. This is consistent with 5 other reports that ADT and radiotherapy is not associated with increased CV mortality. A CaPSURE report in 2007 reported a 4% increased risk of CV death with ADT in patients who had radical prostatectomy. An ADT increase in non-cancer CV mortality may possibly occur, through other mechanisms, such as additive with diabetes.

Presented by J. A. Efstathiou at the American Society of Clinical Oncology (ASCO) - 2008 Genitourinary Cancers Symposium - A Multidisciplinary Approach - February 14-16, 2008 San Francisco, California, USA

Reported by UroToday.com Contributing Editor Christopher P. Evans, MD, FACS Professor & Chairman Department of Urology University of California, Davis, School of Medicine Sacramento, CA

UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice.

To access the latest urology news releases from UroToday, go to: www.urotoday.com

----------------------------
Copyright © 2007 - UroToday
Reproduced for Medical News Today with permission of UroToday.
----------------------------

Article adapted by Medical News Today from original press release.
Visit our prostate / prostate cancer section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Urology Today. "ASCO GU 2008 - Cardiovascular Mortality Following Androgen Deprivation Therapy For Locally Advanced Prostate Cancer: Analysis Of ROG 85-31." Medical News Today. MediLexicon, Intl., 16 Feb. 2008. Web.
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/97594.php>

APA
Urology Today. (2008, February 16). "ASCO GU 2008 - Cardiovascular Mortality Following Androgen Deprivation Therapy For Locally Advanced Prostate Cancer: Analysis Of ROG 85-31." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/97594.php.

Please note: If no author information is provided, the source is cited instead.


Prostate / Prostate Cancer

Most Popular Articles



Follow Our Prostate News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Prostate / Prostate Cancer Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »